08:45 AM EDT, 07/17/2024 (MT Newswires) -- BioCardia ( BCDA ) said Wednesday that it was granted a patent for its method for transseptal access to the heart using a steerable catheter based on the company's Morph DNA technology.

The patent issued by the US Patent Office protects the company's products through 2035, BioCardia ( BCDA ) said.

BioCardia's ( BCDA ) stock was up 1.3% in recent Wednesday premarket activity.

Price: 3.1900, Change: +0.04, Percent Change: +1.27